Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Prostate cancer (PCa) is a significant global health concern.
• The insulin-like growth factor (IGF) family, including ligands, receptors, and binding proteins, is implicated in cancer development.
• Previous studies show conflicting results regarding IGF family expression and PCa risk due to tumor heterogeneity and methodological variations.

Purpose of the Study:

• To review and synthesize current knowledge on the role of the IGF system in prostate tumorigenesis.
• To elucidate the regulatory mechanisms of IGF signaling in PCa.
• To highlight the potential of targeting IGF signaling in PCa treatment strategies.

Main Methods:

• Literature review of studies investigating the IGF family and prostate cancer.
• Analysis of existing data on IGF family member expression in prostate tumors.
• Synthesis of findings on the functional roles of IGF signaling in PCa progression and metastasis.

Main Results:

• IGF-I and IGF-II are potent mitogens linked to increased cancer risk, including PCa.
• Despite controversies, several IGF family members demonstrably influence PCa development, metastasis, and androgen-independent progression.
• The IGF system plays a multifaceted role in regulating prostate cancer cell growth and survival.

Conclusions:

• The IGF system is a key regulator in prostate cancer development and progression.
• Further research into IGF signaling pathways is essential for understanding PCa pathogenesis.
• Targeting the IGF system holds promise as a component of comprehensive PCa treatment strategies.